Tag: nasdaq:vrtx

November 24, 2019

5 Top NASDAQ Biotech and Pharma Stocks: Fulcrum Climbs 73 Percent

Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
November 19, 2019

CRISPR and Vertex Release Positive Gene-editing Results

This is the first time CRISPR/Cas9 gene-editing technology has been used in human trials to treat genetic diseases.
November 12, 2019

Vertex Announces Northern Ireland Offer Accepted for Cystic Fibrosis Treatments

The Regional Pharmaceutical Procurement Service in Northern Ireland has accepted an offer for cystic fibrosis treatments.
September 25, 2019

AzurRx BioPharma Dips on Phase 2 Trial Results for MS1819

Shares of the company tumbled more than 20 percent on Wednesday following the release of Phase 2 trial results for...
May 28, 2019

8 Small Biotech ETFs

Want to invest in small biotech ETFs? Here we profile eight that life science investors may want to look into.
December 13, 2018

Pharma Trends 2018: Drug Pricing Takes Center Stage

Knowing what pharma trends influenced the market this year may be key for new and ongoing investing opportunities.
November 29, 2018

Vertex’s Cystic Fibrosis Drug Receives Nod from EU

KALYDECO is a cystic fibrosis drug for patients with certain mutations in the CFTR gene. It is now for patients...